Butyric Acid

Butyric Acid

SCHEMBL3939998

CCCC(=O)O.CCCCCC.CCOC(C)=O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
HSD17B10 Q99714 2/20 0.58
LMNA P02545 1/20 0.58
FFAR3 O14843 1/20 0.54
HDAC3 O15379 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
AKR1B1 P15121 1/20 0.54
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 4/20 0.52
PTPN1 P18031 3/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
KMT2A Q03164 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL20720532 0.98 ALDH1A1 (0.56) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Butyric Acid SCHEMBL31546267 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Butyric Acid SCHEMBL845266 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Hexanoate SCHEMBL5015262 0.92 AKR1B1 (0.67) ALDH1A1HSD17B10LMNAAKR1B1GPR84
Butyric Acid SCHEMBL27885948 0.91 ALDH1A1 (0.64) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Butyric Acid SCHEMBL31534016 0.91 PAM (0.56) ALDH1A1HSD17B10LMNAAKR1B1GPR84
Stearic Acid SCHEMBL8132485 0.90 GPR84 (0.68) ALDH1A1HSD17B10LMNAAKR1B1GPR84
Heptanoate SCHEMBL9706299 0.90 GPR84 (0.68) ALDH1A1HSD17B10LMNAAKR1B1GPR84
Nonanoate SCHEMBL27628803 0.90 GPR84 (0.68) ALDH1A1HSD17B10LMNAAKR1B1GPR84
Octanoic Acid SCHEMBL7413713 0.90 GPR84 (0.68) ALDH1A1HSD17B10LMNAAKR1B1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2386546-B1 NOVEL PYRAZOLE-3-CARBOXAMIDE DERIVATE HAVING 5-HT2B RECEPTOR ANTAGONIST ACTIVITY RAQUALIA PHARMA INC (JP) 2015-08-19 EP disclosed
EP-2049541-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-04-22 EP disclosed
WO-2008016192-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 WO disclosed
EP-0510700-A2 Azole compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-10-28 EP disclosed
US-5037852-A Treating or reverting hair loss, acne or prostatic hypertrophy ONO PHARMACEUTICAL CO., LTD. (JP) 1991-08-06 US disclosed